- G32.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM G32.81 became effective on October 1, 2022.
- This is the American ICD-10-CM version of G32.81 – other international versions of ICD-10 G32.81 may differ.
ICD-10-CM G32.81 is grouped within Diagnostic Related Group(s):
- 058 Multiple sclerosis and cerebellar ataxia with mcc
- 059 Multiple sclerosis and cerebellar ataxia with cc
- 060 Multiple sclerosis and cerebellar ataxia without cc/mcc
Type 1 Excludes
- systemic atrophy primarily affecting the central nervous system in alcoholic cerebellar ataxia (G31.2)
- systemic atrophy primarily affecting the central nervous system in myxedema (G13.2)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to G32.81:
- specified disease NEC > in G31.2